Development of foot-and-mouth disease virus (FMDV) serotype O virus-like-particles (VLPs) vaccine and evaluation of its potency

Antiviral Research

Volumn 96, Issue 3, 2012, Pages 288-295

  Mohana Subramanian, B ^a   Madhanmohan, M ^a   Sriraman, Rajan ^a   Chandrasekhar Reddy, R V ^a   Yuvaraj, S ^a   Manikumar, Kankipati ^a   Rajalakshmi, S ^a   Nagendrakumar, S B ^a   Rana, Samir Kumar ^a   Srinivasan, V A ^a  

^a Indian Immunologicals Limited   (India)

Author keywords

Cattle challenge; FMDV; VLP vaccine

Indexed keywords

ADJUVANT; BACULOVIRUS VECTOR; CIRCOFLEX; FOOT AND MOUTH DISEASE VACCINE; NEUTRALIZING ANTIBODY; PORCILIS PESTI; RECOMBINANT PROTEIN; STRUCTURAL PROTEIN; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE; VIRUS PROTEIN;

ANIMAL EXPERIMENT; ANTIBODY TITER; ARTICLE; DRUG POTENCY; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; FOOT AND MOUTH DISEASE VIRUS SEROTYPE O1; GENE SEQUENCE; GENETIC CODE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENE; VIRUS LIKE AGENT;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, NEUTRALIZING; ANTIBODIES, VIRAL; ANTIBODY FORMATION; ANTIGENS, VIRAL; BACULOVIRIDAE; CATTLE; CATTLE DISEASES; CYSTEINE ENDOPEPTIDASES; FLUORESCENT ANTIBODY TECHNIQUE; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENETIC VECTORS; MALE; NEUTRALIZATION TESTS; RNA, VIRAL; SF9 CELLS; VACCINATION; VACCINES, VIRUS-LIKE PARTICLE; VIRAL PROTEINS;

ANIMALIA; BOS; FOOT-AND-MOUTH DISEASE VIRUS;

EID: 84869122874     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.09.019     Document Type: Article

References (34)

1. Balamurugan V., Renji R., Venkatesh G., Reddy G.R., Nair S.P., Ganesh K., Suryanarayana V.V. Protective immune response against foot-and-mouth disease virus challenge in guinea pigs vaccinated with recombinant P1 polyprotein expressed in Pichia pastoris. Arch. Virol. 2005, 150:967-979.
2. Belsham G.J. Distinctive features of foot-and-mouth disease virus, a member of the picornavirus family; aspects of virus protein synthesis, protein processing and structure. Prog. Biophys. Mol. Biol. 1993, 60:241-260.
3. Blanchard P., Mahe D., Cariolet R., Keranflec'h A., Baudouard M.A., Cordioli P., Albina E., Jestin A. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins. Vaccine 2003, 21:4565-4575.
4. Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol. Med. 2006, 119:445-462.
5. Cao Y., Lu Z., Sun J., Bai X., Sun P., Bao H., Chen Y., Guo J., Li D., Liu X., Liu Z. Synthesis of empty capsid-like particles of Asia I foot-and-mouth disease virus in insect cells and their immunogenicity in guinea pigs. Vet. Microbiol. 2009, 137:10-17.
6. Cox M.M. Recombinant protein vaccines produced in insect cells. Vaccine 2012, 30:1759-1766.
7. Cox S.J., Parida S., Voyce C., Reid S.M., Hamblin P.A., Hutchings G., Paton D.J., Barnett P.V. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge. Vaccine 2007, 25:7687-7695.
8. Cox S.J., Voyce C., Parida S., Reid S.M., Hamblin P.A., Paton D.J., Barnett P.V. Protection against direct-contact challenge followingemergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx. Vaccine 2005, 23:1106-1113.
9. Curry S., Fry E., Blakemore W., Abu-Ghazaleh R., Jackson T., King A., Lea S., Newman J., Stuart D. Dissecting the roles of VP0 cleavage and RNA packaging in picornavirus capsid stabilization: the structure of empty capsids of foot-and-mouth disease virus. J. Virol. 1997, 71:9743-9752.
10. Doel T.R. FMD vaccines. Virus Res. 2003, 91:81-89.
11. Fachinger V., Bischoff R., Jedidia S.B., Saalmüller A., Elbers K. The effect of vaccination against porcine circovirus type 2 in pigs suffering from porcine respiratory disease complex. Vaccine 2008, 26:1488-1499.
12. Golding S.M., Hedger R.S., Talbot P. Radial immuno-diffusion and serum neutralisation techniques for the assay of antibodies to swine vesicular disease. Res. Vet. Sci. 1976, 20:142-147.
13. Goris N., Merkelbach-Peters P., Diev V.I., Verloo D., Zakharov V.M., Kraft H.P., De Clercq K. European pharmacopoeia foot-and-mouth disease vaccine potency testing in cattle: between test variability and its consequences. Vaccine 2007, 25:3373-3379.
14. Grubman M.J., Moraes M.P., Schutta C., Barrera J., Neilan J., Ettyreddy D., Butman B.T., Brough D.E., Brake D.A. Adenovirus serotype 5-vectored foot-and-mouth disease subunit vaccines: the first decade. Future Virol. 2010, 5:51-64.
15. Grubman M.J., Zellner M., Bablanian G., Mason P.W., Piccone M.E. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology 1995, 213:581-589.
16. Hamblin C., Armstrong R.M., Hedger R.S. A rapid enzyme linked immunosorbent assay for the detection of foot and mouth disease viruses in epithelial tissues. Vet. Microbiol. 1984, 9:435-443.
17. Karber G. Beitrag zur kollektiven Behandlung pharmakologischer Reihenversuche. Arch. Exper. Pathol. Pharmakol. 1931, 162:480-487.
18. Lewis S.A., Morgan D.O., Grubman M.J. Expression, processing, and assembly of foot-and-mouth disease virus capsid structures in heterologous systems: induction of a neutralizing antibody response in guinea pigs. J. Virol. 1991, 65:6572-6580.
19. Li Y., Aggarwal N., Takamatsu H.H., Sterling C.M., Voyce C., Barnett P.V. Enhancing immune responses against a plasmid DNA vaccine encoding a FMDV empty capsid from serotype O. Vaccine 2006, 24:4602-4606.
20. Li Z., Yi Y., Yin X., Zhang Z., Liu J. Expression of foot-and-mouth disease virus capsid proteins in silkworm-baculovirus expression system and its utilization as a subunit vaccine. PLoS ONE 2008, 3:e2273.
21. Li Z., Yin X., Yi Y., Li X., Li B., Lan X., Zhang Z., Liu J. FMD subunit vaccine produced using a silkworm-baculovirus expression system: protective efficacy against two type Asia1 isolates in cattle. Vet. Microbiol. 2011, 149:99-103.
22. Moraes M.P., Mayr G.A., Mason P.W., Grubman M.J. Early protection against homologous challenge after a single dose of replication-defective human adenovirus type 5 expressing capsid proteins of foot-and-mouth disease virus (FMDV) strain A24. Vaccine 2002, 20:1631-1639.
23. 1 Manisa antigen. Vaccine 2011, 29:1906-1912.
24. Oem J.K., Park J.H., Lee K.N., Kim Y.J., Kye S.J., Park J.Y., Song H.J. Characterization of recombinant foot-and-mouth disease virus pentamer-like structures expressed by baculovirus and their use as diagnostic antigens in a blocking ELISA. Vaccine 2007, 25:4112-4121.
25. Pacheco J.M., Brum M.C., Moraes M.P., Golde W.T., Grubman M.J. Rapid protection of cattle from direct challenge with foot-and-mouth disease virus (FMDV) by a single inoculation with an adenovirus-vectored FMDV subunit vaccine. Virology 2005, 337:205-209.
26. Project Directorate on FMD Annual Report, 2011. Project Directorate on Foot-and-Mouth Disease, Indian Veterinary Research Institute, Mukteshwar - Kumaon, Nainital, India.
27. Quan M., Murphy C.M., Zhang Z., Alexandersen S. Determinants of early foot-and-mouth disease virus dynamics in pigs. J. Comp. Pathol. 2004, 131:294-307.
28. Reid S.M., Ferris N.P., Hutchings G.H., Zhang Z., Belsham G.J., Alexandersen S. Detection of all seven serotypes of foot- and-mouth disease virus by real-time, fluorogenic reverse transcription polymerase chain reaction assay. J. Virol. Methods 2002, 105:67-80.
29. Shaw A.E., Reid S.M., Ebert K., Hutchings G.H., Ferris N.P., King D.P. Implementation of a one-step real-time RT-PCR protocol for diagnosis of foot-and-mouth disease. J. Virol. Methods 2007, 143:81-85.
30. Snowdon W.A. Growth of foot-and-mouth disease virus in monolayer cultures of calf thyroid cells. Nature 1966, 210:1079-1080.
31. Sorensen K.J., Madsen K.G., Madsen E.S., Salt J.S., Nqindi J., Mackay D.K.J. Differentiation of infection from vaccination in foot and-mouth disease by the detection of antibodies to the non-structural proteins 3D 3AB and 3ABC in ELISA using antigens expressed in Baculovirus. Arch. Virol. 1998, 143:1461-1476.
32. Thacker E.E., Timares L., Matthews Q.L. Strategies to overcome host immunity to adenovirus vectors in vaccine development. Expert Rev. Vaccines 2009, 8:761-777.
33. van Aarle P. Suitability of an E2 subunit vaccine of classical swine fever in combination with the E(rns)-marker-test for eradication through vaccination. Dev. Biol. (Basel) 2003, 114:193-200.
34. Vianna Filho Y.L., Astudillo V., Gomes I., Ferńandez G., Rozas C.E.E., Ravison J.A., Alonso A. Potency control of foot-and-mouth disease vaccine in cattle. Comparison of the 50% protective dose and the protection against generalization. Vaccine 1993, 11:1424-1428.